Cargando…
The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems
Ophthalmic drug delivery to the posterior segment of the eye has been challenging due to the complex ocular anatomy. Intravitreal injection of drugs was introduced to deliver therapeutic doses in the posterior segment. Different posterior segment diseases including age-related macular degeneration,...
Autores principales: | Aceves-Franco, Luis Abraham, Sanchez-Aguilar, Oscar Eduardo, Barragan-Arias, Allen Rafael, Ponce-Gallegos, Marco Antonio, Navarro-Partida, Jose, Santos, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377205/ https://www.ncbi.nlm.nih.gov/pubmed/37509540 http://dx.doi.org/10.3390/biomedicines11071901 |
Ejemplares similares
-
Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient
por: Fazelat, Ahad, et al.
Publicado: (2011) -
Patients treated with intravitreal triamcinolone acetonide
por: Gallenga, Pier E, et al.
Publicado: (2008) -
Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
por: Navarro-Partida, Jose, et al.
Publicado: (2021) -
Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits
por: Ye, You-Fan, et al.
Publicado: (2014) -
Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
por: Suh, Shin Cho, et al.
Publicado: (2007)